Results 251 to 260 of about 143,935 (260)

Causes of death – other than progressive leukemia – in childhood acute lymphoblastic (ALL) and myeloid leukemia (AML): the Dutch Childhood Oncology Group experience

Leukemia, 2005
W A Kamps, Kamps W A, Veerman A J P
exaly  

Constitutive NF-κB activation in AML: Causes and treatment strategies

Critical Reviews in Oncology/Hematology, 2016
Jan Jacob Schuringa, E Vellenga
exaly  

Allogeneic bone marrow transplantation improves the outcome of de novo AML with trilineage dysplasia (AML-TLD)

Leukemia, 2000
Matsuo T, Miyazaki Y, Kuriyama K
exaly  

A European network for AML

The Hematology Journal, 2004
openaire   +2 more sources

PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1

Cell Stem Cell
Jianlong Wang, Mingjiang Xu
exaly  

Immunotherapeutic targeting of surfaceome heterogeneity in AML

Cell Reports
Jean-François Spinella, Marie-Eve Bordeleau   +1 more
exaly  

AML-083 AML in Pregnancy: Case Series

Clinical Lymphoma Myeloma and Leukemia
Neha Ganju, Tribikram Panda, Gurleen Oberoi, Mukul Agarwal, Manoranjan Mahapatra   +4 more
openaire   +1 more source

Novel insights and therapeutic approaches in secondary AML

Frontiers in Oncology
Giovanni Marconi, Francesco Lanza, Michela Rondoni   +2 more
exaly  

AML

2003
openaire   +1 more source

TET2 mutations contribute to adverse prognosis in acute myeloid leukemia (AML): results from a comprehensive analysis of 502 AML cases and the Beat AML public database

Clinical and Experimental Medicine
Qian Jiang, Xiaojun Huang, Ying-Jun Chang   +2 more
exaly